These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 23912455)

  • 1. Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma development.
    Dutruel C; Bergmann F; Rooman I; Zucknick M; Weichenhan D; Geiselhart L; Kaffenberger T; Rachakonda PS; Bauer A; Giese N; Hong C; Xie H; Costello JF; Hoheisel J; Kumar R; Rehli M; Schirmacher P; Werner J; Plass C; Popanda O; Schmezer P
    Oncogene; 2014 Jun; 33(26):3401-10. PubMed ID: 23912455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models.
    Shen R; Wang Q; Cheng S; Liu T; Jiang H; Zhu J; Wu Y; Wang L
    Cancer Lett; 2013 Oct; 339(1):135-43. PubMed ID: 23887057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
    Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
    Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
    Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z
    Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes.
    Amato E; Barbi S; Fassan M; Luchini C; Vicentini C; Brunelli M; Malleo G; Scarpa A; Malpeli G
    BMC Cancer; 2016 Jan; 16():11. PubMed ID: 26754001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.
    Aichler M; Seiler C; Tost M; Siveke J; Mazur PK; Da Silva-Buttkus P; Bartsch DK; Langer P; Chiblak S; Dürr A; Höfler H; Klöppel G; Müller-Decker K; Brielmeier M; Esposito I
    J Pathol; 2012 Apr; 226(5):723-34. PubMed ID: 21984419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
    Zhao L; Cui Q; Lu Z; Chen J
    Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.
    Kayed H; Bekasi S; Keleg S; Michalski CW; Giese T; Friess H; Kleeff J
    Mol Cancer; 2007 Dec; 6():83. PubMed ID: 18163903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of a disintegrin and metalloproteinase 17/tumor necrosis factor-alpha converting enzyme increases the malignant potential in human pancreatic ductal adenocarcinoma.
    Ringel J; Jesnowski R; Moniaux N; Lüttges J; Ringel J; Choudhury A; Batra SK; Klöppel G; Löhr M
    Cancer Res; 2006 Sep; 66(18):9045-53. PubMed ID: 16982746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1.
    Wang P; Chen L; Zhang J; Chen H; Fan J; Wang K; Luo J; Chen Z; Meng Z; Liu L
    Oncogene; 2014 Jan; 33(4):514-24. PubMed ID: 23334332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential methylation landscape of pancreatic ductal adenocarcinoma and its precancerous lesions.
    Bararia A; Dey S; Gulati S; Ghatak S; Ghosh S; Banerjee S; Sikdar N
    Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):205-217. PubMed ID: 32312637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of urocortin in pancreatic ductal adenocarcinoma and pancreatic intraepithelial neoplasia.
    Cheng MF; Tsai WC; Hsia KT; Yang YS; Jin JS
    APMIS; 2014 Feb; 122(2):147-54. PubMed ID: 23755913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression and promoter methylation of the menin tumor suppressor in pancreatic ductal adenocarcinoma.
    Cavallari I; Silic-Benussi M; Rende F; Martines A; Fogar P; Basso D; Vella MD; Pedrazzoli S; Herman JG; Chieco-Bianchi L; Esposito G; Ciminale V; D'Agostino DM
    Genes Chromosomes Cancer; 2009 May; 48(5):383-96. PubMed ID: 19170121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis.
    Kayed H; Kleeff J; Keleg S; Felix K; Giese T; Berger MR; Büchler MW; Friess H
    Cancer Lett; 2007 Jan; 245(1-2):171-83. PubMed ID: 16488077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between ECT2 gene expression and methylation change of ECT2 promoter region in pancreatic cancer.
    Zhang ML; Lu S; Zhou L; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):533-8. PubMed ID: 18842503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic silencing of the kinase tumor suppressor WNK2 is tumor-type and tumor-grade specific.
    Jun P; Hong C; Lal A; Wong JM; McDermott MW; Bollen AW; Plass C; Held WA; Smiraglia DJ; Costello JF
    Neuro Oncol; 2009 Aug; 11(4):414-22. PubMed ID: 19001526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Silencing of GNMT Gene in Pancreatic Adenocarcinoma.
    Botezatu A; Bleotu C; Nastase A; Anton G; Bacalbasa N; Duda D; Dima SO; Popescu I
    Cancer Genomics Proteomics; 2015; 12(1):21-30. PubMed ID: 25560641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling.
    Sato N; Matsubayashi H; Abe T; Fukushima N; Goggins M
    Clin Cancer Res; 2005 Jul; 11(13):4681-8. PubMed ID: 16000561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity status of D9S105 marker is associated with downregulation of Krüppel-like factor 4 expression in pancreatic ductal adenocarcinoma and pancreatic intraepithelial lesions.
    Funel N; Morelli M; Giovannetti E; Del Chiaro M; Pollina LE; Mosca F; Boggi U; Cavazzana A; Campani D
    Pancreatology; 2011; 11(1):30-42. PubMed ID: 21412023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma.
    Wang C; Sun Y; Wu H; Yu S; Zhang L; Meng Y; Liu M; Yang H; Liu P; Mao X; Lu Z; Chen J
    Tumour Biol; 2015 Dec; 36(12):9447-56. PubMed ID: 26124009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.